当前位置: 首页 > 期刊 > 《世界睡眠医学杂志》 > 20188
编号:13575502
丹栀逍遥散联合Lucentis对新生血管性青光眼的临床疗效及血管通透因子和IL—6的影响(4)
http://www.100md.com 2018年8月1日 《世界睡眠医学杂志》 20188
     [13]王斌,吕颂谊.丹栀逍遥散加味治疗肝郁气滞型青光眼60例临床观察[J].浙江中医杂志,2014,49(4):263.

    [14]Kabesha TB,Kabesha D,Maloba V,et al.Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion(report of 2 cases followed at Bukavu Eye Clinic from January to December 31th,2015)[J].J Fr Ophtalmol,2017,40(1):17-21.

    [15]Sun Y,Liang Y,Zhou P,et al.Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term[J].BMC Ophthalmol,2016,16(1):150.

    [16]Liao N,Li C,Jiang H,et al.Neovascular glaucoma:a retrospective review from a tertiary center in China[J].BMC Ophthalmol,2016,16:14.

    [17]Havens SJ,Gulati V.Neovascular Glaucoma[J].Dev Ophthalmol,2016,55:196-204.

    [18]Hou XR,Miao H,Tao Y,et al.Expression of cytokines on the iris of patients with neovascular glaucoma[J].Acta Ophthalmol,2015,93(2):e100-104.

    [19]Ohira S,Inoue T,Shobayashi K,et al.Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection[J].Invest Ophthalmol Vis Sci,2015,56(6):3541-3548.

    [20]李莉,劉升强,王帅,等.血清及房水中VEGF、IL-6水平与新生血管性青光眼的相关性研究[J].临床眼科杂志,2011,19(6):490-493., http://www.100md.com(黄继琴 陈莉 杨顺书 方一惟)
上一页1 2 3 4